Correction: Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma.

Lenz, Georg; Hawkes, Eliza; Verhoef, Gregor; Haioun, Corinne; Thye Lim, Soon; Seog Heo, Dae; Ardeshna, Kirit; Chong, Geoffrey; Haaber, Jacob; Shi, Wei; Gorbatchevsky, Igor; Lippert, Susanne; Hiemeyer, Florian; Piraino, Paolo; Beckmann, Georg; Peña, Carol; Buvaylo, Viktoriya; Childs, Barrett H; Salles, Gilles

Lenz, Georg; Hawkes, Eliza; Verhoef, Gregor; Haioun, Corinne; Thye Lim, Soon; Seog Heo, Dae; Ardeshna, Kirit; Chong, Geoffrey; Haaber, Jacob; Shi, Wei; Gorbatchevsky, Igor; Lippert, Susanne; Hiemeyer, Florian; Piraino, Paolo; Beckmann, Georg; Peña, Carol; Buvaylo, Viktoriya; Childs, Barrett H; Salles, Gilles.

Afiliação

Lenz G; Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Münster, Münster, Germany. georg.lenz@ukmuenster.de.
Hawkes E; Eastern Health Clinical School, Monash University, Olivia Newton John Cancer Research and Wellness Centre, Melbourne, VIC, Australia.
Verhoef G; University Hospitals Leuven, Leuven, Belgium.
Haioun C; Lymphoid Malignancies Unit, Groupe Hospitalier Henri Mondor-Albert Chenevier, Creteil, France.
Thye Lim S; National Cancer Centre Singapore and Duke-NUS Medical School, Singapore, Singapore.
Seog Heo D; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Ardeshna K; University College London Hospitals NHS Foundation Trust, London, UK.
Chong G; Ballarat Regional Integrated Cancer Centre, Ballarat, VIC, Australia.
Haaber J; Department of Hematology, Odense University Hospital, Odense, Denmark.
Shi W; Bayer China, Beijing, China.
Gorbatchevsky I; Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ, USA.
Lippert S; Pharmaceuticals Division, Bayer AG, Berlin, Germany.
Hiemeyer F; Pharmaceuticals Division, Bayer AG, Berlin, Germany.
Piraino P; Pharmaceuticals Division, Bayer AG, Berlin, Germany.
Beckmann G; Pharmaceuticals Division, Bayer AG, Berlin, Germany.
Peña C; Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ, USA.
Buvaylo V; Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ, USA.
Childs BH; Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ, USA.
Salles G; Hospices Civils de Lyon, Université de Lyon, Centre Hospitalier Lyon-Sud, Service d'hématologie, Lyon, France.

Leukemia ; 38(2): 469-472, 2024 Feb.

Article em En | MEDLINE | ID: mdl-38200221

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google